Showing results (11-20 of 298) with videos related to
Sort By:
Pageof 30
Journal of Biopharmaceutical Statistics|April 5, 2014
Sample size consideration for immunoassay screening cut-point determinationJianchun Zhang, Lanju Zhang, Harry YangVaccine|March 16, 2010
A probabilistic model for risk assessment of residual host cell DNA in biological productsHarry Yang, Lanju Zhang, Mark GalinskiJournal of Biopharmaceutical Statistics|January 8, 2009
Test homogeneity of risk difference across subgroups in clinical trialsLanju Zhang, Harry Yang, Iksung ChoPharmaceutical Development and Technology|November 12, 2014
Risk management for moisture related effects in dry manufacturing processes: a statistical approachJorge Quiroz, John Strong, Lanju ZhangBiometrical Journal. Biometrische Zeitschrift|August 28, 2007
Optimal response-adaptive designs for continuous responses in phase III trialsAtanu Biswas, Rahul Bhattachary, Lanju ZhangValue in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|August 17, 2014
Two approaches to incorporate clinical data uncertainty into multiple criteria decision analysis for benefit-risk assessment of medicinal productsShihua Wen, Lanju Zhang, Bo YangScientific Reports|June 12, 2026
Joint association of triglyceride-glucose index and atherogenic lipid markers with incident stroke riskLaiang Yao, Guiling Sun, Lanju Zhang, et al.Journal of Immunological Methods|January 12, 2013
Statistical methods and tool for cut point analysis in immunogenicity assaysLanju Zhang, Jianchun Jason Zhang, Robert J Kubiak, et al.Journal of Biopharmaceutical Statistics|January 16, 2010
Tolerance limits for a ratio of normal random variablesLanju Zhang, Thomas Mathew, Harry Yang, et al.Journal of Biopharmaceutical Statistics|October 31, 2014
Non-normal random effects models for immunogenicity assay cut point determinationJianchun Zhang, Binbing Yu, Lanju Zhang, et al.Pageof 30